Hohlfeld, Reinhard; Dornmair, Klaus; Meinl, Edgar; Wekerle, Hartmut (2016). «The search for the target antigens of multiple sclerosis, part 1: Autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets». The Lancet Neurology. 15 (2): 198–209. doi:10.1016/S1474-4422(15)00334-8. PMID26724103.
Katz, U; Shoenfeld, Y; Zandman-Goddard, G (2011). «Update on intravenous immunoglobulins (IVIg) mechanisms of action and off- label use in autoimmune diseases». Current Pharmaceutical Design. 17 (29): 3166–75. doi:10.2174/138161211798157540. PMID21864262.
Witebsky E, Rose NR, Terplan K, Paine JR, Egan RW (1957). «Chronic thyroiditis and autoimmunization». J. Am. Med. Assoc. 164 (13): 1439–47. doi:10.1001/jama.1957.02980130015004. PMID13448890.
Wucherpfennig KW, Strominger JL (1995). «Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein». Cell. 80 (5): 695–705. doi:10.1016/0092-8674(95)90348-8. PMID7534214.
Rook, Graham A. W. (2011 թ․ նոյեմբերի 17). «Hygiene Hypothesis and Autoimmune Diseases». Clinical Reviews in Allergy & Immunology. 42 (1): 5–15. doi:10.1007/s12016-011-8285-8. PMID22090147.
Jacobson, DL; Gange, SJ; Rose, NR; Graham, NM (September 1997). «Epidemiology and estimated population burden of selected autoimmune diseases in the United States». Clinical Immunology and Immunopathology. 84 (3): 223–43. doi:10.1006/clin.1997.4412. PMID9281381.
Hayter, SM; Cook, MC (August 2012). «Updated assessment of the prevalence, spectrum and case definition of autoimmune disease». Autoimmunity Reviews. 11 (10): 754–65. doi:10.1016/j.autrev.2012.02.001. PMID22387972.
Böhm I (2003). «Disruption of the cytoskeleton after apoptosis induction by autoantibodies». Autoimmunity. 36 (3): 183–9. doi:10.1080/0891693031000105617. PMID12911286.
Hohlfeld, Reinhard; Dornmair, Klaus; Meinl, Edgar; Wekerle, Hartmut (2016). «The search for the target antigens of multiple sclerosis, part 1: Autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets». The Lancet Neurology. 15 (2): 198–209. doi:10.1016/S1474-4422(15)00334-8. PMID26724103.
Katz, U; Shoenfeld, Y; Zandman-Goddard, G (2011). «Update on intravenous immunoglobulins (IVIg) mechanisms of action and off- label use in autoimmune diseases». Current Pharmaceutical Design. 17 (29): 3166–75. doi:10.2174/138161211798157540. PMID21864262.
Witebsky E, Rose NR, Terplan K, Paine JR, Egan RW (1957). «Chronic thyroiditis and autoimmunization». J. Am. Med. Assoc. 164 (13): 1439–47. doi:10.1001/jama.1957.02980130015004. PMID13448890.
Wucherpfennig KW, Strominger JL (1995). «Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein». Cell. 80 (5): 695–705. doi:10.1016/0092-8674(95)90348-8. PMID7534214.
Rook, Graham A. W. (2011 թ․ նոյեմբերի 17). «Hygiene Hypothesis and Autoimmune Diseases». Clinical Reviews in Allergy & Immunology. 42 (1): 5–15. doi:10.1007/s12016-011-8285-8. PMID22090147.
Jacobson, DL; Gange, SJ; Rose, NR; Graham, NM (September 1997). «Epidemiology and estimated population burden of selected autoimmune diseases in the United States». Clinical Immunology and Immunopathology. 84 (3): 223–43. doi:10.1006/clin.1997.4412. PMID9281381.
Hayter, SM; Cook, MC (August 2012). «Updated assessment of the prevalence, spectrum and case definition of autoimmune disease». Autoimmunity Reviews. 11 (10): 754–65. doi:10.1016/j.autrev.2012.02.001. PMID22387972.
Böhm I (2003). «Disruption of the cytoskeleton after apoptosis induction by autoantibodies». Autoimmunity. 36 (3): 183–9. doi:10.1080/0891693031000105617. PMID12911286.